Champions Oncology
CSBR
CSBR
28 hedge funds and large institutions have $37M invested in Champions Oncology in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
92% less call options, than puts
Call options by funds: $158K | Put options by funds: $2.03M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
28
Holding in Top 10
1
Calls
$158K
Puts
$2.03M
Top Buyers
| 1 | +$53.2K | |
| 2 | +$25.5K | |
| 3 | +$23.5K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$16K |
Top Sellers
| 1 | -$180K | |
| 2 | -$97K | |
| 3 | -$44K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$32.5K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$27.1K |